Wellgistics Health, Inc. announced the closing of its initial public offering (IPO) on February 24, 2025. The company sold 888,889 shares of its common stock at a public offering price of $4.50 per share. This offering generated gross proceeds of $4.0 million for the company.
The shares commenced trading on the Nasdaq Capital Market on February 21, 2025, under the ticker symbol "WGRX." Net proceeds from the offering, after deducting underwriting discounts and other expenses, are intended for general corporate purposes. These purposes include working capital, marketing initiatives, and capital expenditures to support the company's growth.
The successful completion of the IPO provides Wellgistics Health with capital to advance its vision of building a "micro health ecosystem." This ecosystem integrates technology, wholesale operations, and pharmacy services to digitize the prescription journey. The company aims to improve patient access, price transparency, and medication adherence in the U.S. healthcare market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.